Ependymoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 20:13, 20 August 2015
|
Ependymoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ependymoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Ependymoma epidemiology and demographics |
|
Risk calculators and risk factors for Ependymoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ependymomas make up about 5% of adult intracranial gliomas and up to 9% of childhood tumors of the central nervous system (CNS).
Epidemiology and Demographics
Incidence
- Childhood Ependymoma represents about 200 cases per year in the United States[1].
Age
- Their occurrence seems to peak at age 5 years and then again at age 35.
- Subependymoma usually affects people over 40 years of age.
Gender
- Subependymoma more often affects men than women.
References
- ↑ National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq